AI Science Tracker
EN

CT learning detects gastric cancer downstaging after chemotherapy

Nanjing University; Jinling Hospital; Deepwise · 28 Apr 2021 · medicine

Discovery

CT learning detects gastric cancer downstaging after chemotherapy

Source check: Source checked. Not independent scientific confirmation.

Finding: Linear support-vector models analyzed baseline and restaging CT in a retrospective 292-patient gastric-cancer study. Models were evaluated in two separate testing cohorts against downstaging defined by baseline clinical and postoperative pathological stages; restaging AUCs were 0.922 and 0.850. The study did not demonstrate improved surgical decisions, and selected images, small same-centre tests and inconsistent abstract cohort labels limit interpretation.

Technology: Linear support-vector classifier; radiomic feature selection

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Linear support-vector classifiers learn relationships between selected CT texture features and recorded post-chemotherapy downstaging.
Test and result
Model development with nested cross-validation, followed by two held-out same-centre clinical testing cohorts and a postoperative pathology-based stage reference.
Limitation / still unknown
Prospective decision benefit and multicentre generalization remain unestablished; clinical baseline staging can be inaccurate, and low-quality images were excluded.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8523390/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.